ID   PTK6_HUMAN              Reviewed;         451 AA.
AC   Q13882; B2RCR3; Q58F01;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-OCT-2010, entry version 116.
DE   RecName: Full=Protein-tyrosine kinase 6;
DE            EC=2.7.10.2;
DE   AltName: Full=Breast tumor kinase;
DE   AltName: Full=Tyrosine-protein kinase BRK;
GN   Name=PTK6; Synonyms=BRK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary tumor;
RX   MEDLINE=94309916; PubMed=8036022;
RA   Mitchell P.J., Barker K.T., Martindale J.E., Kamalati T., Lowe P.N.,
RA   Page M.J., Gusterson B.A., Crompton M.R.;
RT   "Cloning and characterisation of cDNAs encoding a novel non-receptor
RT   tyrosine kinase, brk, expressed in human breast tumours.";
RL   Oncogene 9:2383-2390(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Melanocyte;
RX   MEDLINE=98419955; PubMed=9749526;
RA   Lee H.-Y., Kim M., Lee K.-H., Kang K.-N., Lee S.-T.;
RT   "Exon-intron structure of the human PTK6 gene demonstrates that PTK6
RT   constitutes a distinct family of non-receptor tyrosine kinase.";
RL   Mol. Cells 8:401-407(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=21638749; PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CHARACTERIZATION, AND MUTAGENESIS OF LYS-219 AND TYR-447.
RX   MEDLINE=97094849; PubMed=8940083; DOI=10.1074/jbc.271.48.30956;
RA   Kamalati T., Jolin H.E., Mitchell P.J., Barker K.T., Jackson L.E.,
RA   Dean C.J., Page M.J., Gusterson B.A., Crompton M.R.;
RT   "Brk, a breast tumor-derived non-receptor protein-tyrosine kinase,
RT   sensitizes mammary epithelial cells to epidermal growth factor.";
RL   J. Biol. Chem. 271:30956-30963(1996).
RN   [7]
RP   FUNCTION, INTERACTION WITH STAP2, AND MUTAGENESIS OF TRP-44; TYR-66;
RP   ARG-105 AND LYS-219.
RX   MEDLINE=20438687; PubMed=10980601; DOI=10.1038/sj.onc.1203775;
RA   Mitchell P.J., Sara E.A., Crompton M.R.;
RT   "A novel adaptor-like protein which is a substrate for the non-
RT   receptor tyrosine kinase, BRK.";
RL   Oncogene 19:4273-4282(2000).
RN   [8]
RP   INTERACTION WITH KHDRBS1.
RX   PubMed=10913193; DOI=10.1128/MCB.20.16.6114-6126.2000;
RA   Derry J.J., Richard S., Valderrama Carvajal H., Ye X., Vasioukhin V.,
RA   Cochrane A.W., Chen T., Tyner A.L.;
RT   "Sik (BRK) phosphorylates Sam68 in the nucleus and negatively
RT   regulates its RNA binding ability.";
RL   Mol. Cell. Biol. 20:6114-6126(2000).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12833144; DOI=10.1038/sj.onc.1206465;
RA   Derry J.J., Prins G.S., Ray V., Tyner A.L.;
RT   "Altered localization and activity of the intracellular tyrosine
RT   kinase BRK/Sik in prostate tumor cells.";
RL   Oncogene 22:4212-4220(2003).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-219 AND TYR-447,
RP   AND PHOSPHORYLATION.
RX   PubMed=15471878; DOI=10.1074/jbc.M409579200;
RA   Haegebarth A., Heap D., Bie W., Derry J.J., Richard S., Tyner A.L.;
RT   "The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the
RT   RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and
RT   SLM-2.";
RL   J. Biol. Chem. 279:54398-54404(2004).
RN   [11]
RP   INTERACTION WITH IRS4.
RX   PubMed=15870689; DOI=10.1038/sj.onc.1208721;
RA   Qiu H., Zappacosta F., Su W., Annan R.S., Miller W.T.;
RT   "Interaction between Brk kinase and insulin receptor substrate-4.";
RL   Oncogene 24:5656-5664(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=15951569; DOI=10.1074/mcp.M500089-MCP200;
RA   Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,
RA   Lauffenburger D.A., White F.M.;
RT   "Time-resolved mass spectrometry of tyrosine phosphorylation sites in
RT   the epidermal growth factor receptor signaling network reveals dynamic
RT   modules.";
RL   Mol. Cell. Proteomics 4:1240-1250(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [15]
RP   INTERACTION WITH ADAM15.
RX   PubMed=18296648; DOI=10.1158/1541-7786.MCR-07-2028;
RA   Zhong J.L., Poghosyan Z., Pennington C.J., Scott X., Handsley M.M.,
RA   Warn A., Gavrilovic J., Honert K., Kruger A., Span P.N., Sweep F.C.,
RA   Edwards D.R.;
RT   "Distinct functions of natural ADAM-15 cytoplasmic domain variants in
RT   human mammary carcinoma.";
RL   Mol. Cancer Res. 6:383-394(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-114 AND SER-159, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-447, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [18]
RP   STRUCTURE BY NMR OF 75-174.
RX   PubMed=15056653; DOI=10.1074/jbc.M313185200;
RA   Hong E., Shin J., Kim H.I., Lee S.T., Lee W.;
RT   "Solution structure and backbone dynamics of the non-receptor protein-
RT   tyrosine kinase-6 Src homology 2 domain.";
RL   J. Biol. Chem. 279:29700-29708(2004).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-16 AND THR-436.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates KHDRBS1, KHDRBS2, KHDRBS3 and STAP2/BKS.
CC       May function as an intracellular signal transducer in epithelial
CC       tissues. Overexpression in mammary cells leads to mitogenically
CC       sensitization to EGF, and results in a partially transformed
CC       phenotype. Its presence in the nucleus appears to be linked to
CC       suppression of tumor progression.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- ENZYME REGULATION: Activated enzyme seems to have greater access
CC       to its substrates.
CC   -!- SUBUNIT: Interacts with GAP-A.p65 (By similarity). Interacts with
CC       KHDRBS1. Interacts with phosphorylated IRS4. Interacts with
CC       ADAM15.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Colocalizes with
CC       KHDRBS1, KHDRBS2 or KHDRBS3, within the nucleus. In secretory
CC       epithelial cells from prostate adenocarcinoma, nuclear
CC       localization is higher in low-grade and lower in high-grade
CC       regions of the tumors.
CC   -!- TISSUE SPECIFICITY: Epithelia-specific. Very high level in colon
CC       and high levels in small intestine and prostate, and low levels in
CC       some fetal tissues. Expressed at low level in some breast tumors,
CC       but not in normal breast. Also found in melanocytes. Not expressed
CC       in heart, brain, placenta, lung, liver, skeletal muscle, kidney
CC       and pancreas.
CC   -!- PTM: Autophosphorylated. The phosphorylation of Tyr-447 may lead
CC       to the autoinhibition of the enzyme.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. BRK/PTK6/SIK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SH2 domain.
CC   -!- SIMILARITY: Contains 1 SH3 domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X78549; CAA55295.1; -; mRNA.
DR   EMBL; U61412; AAC34935.1; -; Genomic_DNA.
DR   EMBL; U61406; AAC34935.1; JOINED; Genomic_DNA.
DR   EMBL; U61407; AAC34935.1; JOINED; Genomic_DNA.
DR   EMBL; U61408; AAC34935.1; JOINED; Genomic_DNA.
DR   EMBL; U61409; AAC34935.1; JOINED; Genomic_DNA.
DR   EMBL; U61410; AAC34935.1; JOINED; Genomic_DNA.
DR   EMBL; U61411; AAC34935.1; JOINED; Genomic_DNA.
DR   EMBL; AK315232; BAG37660.1; -; mRNA.
DR   EMBL; AL121829; CAC15525.1; -; Genomic_DNA.
DR   EMBL; BC035843; AAH35843.1; -; mRNA.
DR   IPI; IPI00015927; -.
DR   PIR; S49016; S49016.
DR   RefSeq; NP_005966.1; -.
DR   UniGene; Hs.51133; -.
DR   PDB; 1RJA; NMR; -; A=75-174.
DR   PDB; 2KGT; NMR; -; A=1-72.
DR   PDBsum; 1RJA; -.
DR   PDBsum; 2KGT; -.
DR   ProteinModelPortal; Q13882; -.
DR   SMR; Q13882; 11-446.
DR   DIP; DIP-39785N; -.
DR   MINT; MINT-1494499; -.
DR   STRING; Q13882; -.
DR   PhosphoSite; Q13882; -.
DR   PRIDE; Q13882; -.
DR   Ensembl; ENST00000217185; ENSP00000217185; ENSG00000101213.
DR   GeneID; 5753; -.
DR   KEGG; hsa:5753; -.
DR   UCSC; uc002yfg.1; human.
DR   CTD; 5753; -.
DR   GeneCards; GC20M062159; -.
DR   H-InvDB; HIX0027678; -.
DR   HGNC; HGNC:9617; PTK6.
DR   HPA; HPA036070; -.
DR   MIM; 602004; gene.
DR   PharmGKB; PA33960; -.
DR   eggNOG; prNOG14798; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG008761; -.
DR   InParanoid; Q13882; -.
DR   OMA; KLGSGYF; -.
DR   OrthoDB; EOG9ZW7XC; -.
DR   PhylomeDB; Q13882; -.
DR   BRENDA; 2.7.10.2; 247.
DR   BindingDB; Q13882; -.
DR   NextBio; 22386; -.
DR   ArrayExpress; Q13882; -.
DR   Bgee; Q13882; -.
DR   CleanEx; HS_PTK6; -.
DR   Genevestigator; Q13882; -.
DR   GermOnline; ENSG00000101213; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; TAS:ProtInc.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR011511; SH3_2.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR015774; Tyr_kinase_non-rcpt_PTK6.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:3.30.505.10; SH2; 1.
DR   PANTHER; PTHR23256:SF142; PTK6; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50044; SH3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism; SH2 domain;
KW   SH3 domain; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    451       Protein-tyrosine kinase 6.
FT                                /FTId=PRO_0000088133.
FT   DOMAIN       11     72       SH3.
FT   DOMAIN       78    170       SH2.
FT   DOMAIN      191    445       Protein kinase.
FT   NP_BIND     197    205       ATP (By similarity).
FT   ACT_SITE    312    312       Proton acceptor (By similarity).
FT   BINDING     219    219       ATP (By similarity).
FT   MOD_RES     114    114       Phosphotyrosine.
FT   MOD_RES     159    159       Phosphoserine.
FT   MOD_RES     342    342       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     447    447       Phosphotyrosine.
FT   VARIANT      16     16       L -> F (in a renal papillary sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041760.
FT   VARIANT     436    436       A -> T (in dbSNP:rs56145017).
FT                                /FTId=VAR_041761.
FT   MUTAGEN      44     44       W->A: Strong decrease in STAP2
FT                                phosphorylation.
FT   MUTAGEN      66     66       Y->A: Decrease in STAP2 phosphorylation.
FT   MUTAGEN     105    105       R->L: Decrease in STAP2 phosphorylation.
FT   MUTAGEN     219    219       K->M: Abolishes kinase activity and cell
FT                                transformation, and no more
FT                                phosphorylation of STAP2.
FT   MUTAGEN     447    447       Y->F: Decrease in transforming potential
FT                                and increase in the kinase activity
FT                                level.
FT   HELIX        85     92
FT   STRAND      102    106
FT   STRAND      108    112
FT   STRAND      114    118
FT   STRAND      125    131
FT   STRAND      133    135
FT   STRAND      137    140
FT   STRAND      143    147
FT   HELIX       148    157
FT   STRAND      162    164
SQ   SEQUENCE   451 AA;  51834 MW;  CDCAC0EE242E1BD7 CRC64;
     MVSRDQAHLG PKYVGLWDFK SRTDEELSFR AGDVFHVARK EEQWWWATLL DEAGGAVAQG
     YVPHNYLAER ETVESEPWFF GCISRSEAVR RLQAEGNATG AFLIRVSEKP SADYVLSVRD
     TQAVRHYKIW RRAGGRLHLN EAVSFLSLPE LVNYHRAQSL SHGLRLAAPC RKHEPEPLPH
     WDDWERPREE FTLCRKLGSG YFGEVFEGLW KDRVQVAIKV ISRDNLLHQQ MLQSEIQAMK
     KLRHKHILAL YAVVSVGDPV YIITELMAKG SLLELLRDSD EKVLPVSELL DIAWQVAEGM
     CYLESQNYIH RDLAARNILV GENTLCKVGD FGLARLIKED VYLSHDHNIP YKWTAPEALS
     RGHYSTKSDV WSFGILLHEM FSRGQVPYPG MSNHEAFLRV DAGYRMPCPL ECPPSVHKLM
     LTCWCRDPEQ RPCFKALRER LSSFTSYENP T
//
